CDIO Cardio Diagnostics Holdings: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The daily price chart for Cardio Diagnostics (CDIO) shows an EV/EBITDA ratio of 0.00. Cardio Diagnostics is integrating environmental standards into genetic diagnostics by minimizing emissions and digitizing reporting. The business is shielded from external political shocks, as it operates exclusively within the US. Revenue is generated through the sale of epigenetic tests to clinics specializing in the early detection of cardiovascular pathologies.
Summary analytical data breakdowns for cardiodiagnosticsinc.com (CDIO)
- stock price and consensus target price:
- company stock capitalization data:
- book value of equity indicators:
- company liabilities and liquidity data:
Total Debt to Capital Cardio Diagnostics|CDIO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Cardio Diagnostics Holdings|CDIO - Company Aggregate Debts|Debt to Book Capitalization Ratio Cardio Diagnostics Holdings, Inc.|CDIO - Company Long-Term Loans and Borrowings|Company Short-Term Debts Cardio Diagnostics|Quick Ratio cardiodiagnosticsinc.com
- financial results and valuation multiples details:
CDIO - Net Financial Result|Expected Profit Cardio Diagnostics|CDIO - Market Cap to Earnings|Projected Price to Earnings Cardio Diagnostics Holdings|CDIO - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Cardio Diagnostics Holdings, Inc.|CDIO - Operating profit before amortization|Net earnings per share (EPS TTM) Cardio Diagnostics|CDIO - Net earnings per share for the last four quarters|Quarterly EPS earnings growth cardiodiagnosticsinc.com|CDIO - Earnings growth in current year|Earnings growth forecast for next year Cardio Diagnostics
Fundamental company analysis:CDIO (Cardio Diagnostics Holdings, Inc.)
Cardio Diagnostics (CDIO) is scaling the implementation of AI tests for ischemia diagnostics, creating a stable B2B revenue stream. The company's EV/EBITDA multiple compares the total enterprise value, including debt, with its operating profit before taxes and amortization. Analyzing this curve allows for an assessment of asset capitalization efficiency and cash flow sustainability under conditions of high leverage.
Key competitors
Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple QDEL|Enterprise Value to EBITDA Ratio opko.com OPK|EV/EBITDA Multiple CDNA (CareDx Inc)|EV/EBITDA Multiple Maravai LifeSciences Holdings MRVI|FLGT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation LAB (Standard BioTools Corp)|CTKB: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OSUR|XGN (Exagen Inc) - EV/EBITDA Multiple|MDxHealth S.A. (MDXH) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lucid Diagnostics Inc (LUCD)|PRE - Company Value to EBITDA|Insight Molecular Diagnostics Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation TRIB|ProPhase Labs - EV/EBITDA Multiple|AIMD (Ainos Inc) - Enterprise Value to Operating Income Before Depreciation|CODX: EV/EBITDA Multiple|HSCS - Total Company Value to Operating Income Before Depreciation Ratio|BMRA (Biomerica, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple onconetix.gcs-web.com|EV/EBITDA Multiple VRAX|Bluejay Diagnostics Inc (BJDX) - Enterprise Value to EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vermillion AWH|AXDX: Enterprise Value to Operating Income Before Depreciation|CNTG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Enzo Biochem, Inc.|fresh2.co (FRES) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GENE - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ME|PMD (Psychemedics Inc) - Enterprise Value to Operating Income Before Depreciation Ratio
